EUVIMEDEUVIMED entdecken
Crossref

High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer

Yanrong Wen iD, Mengxiang Liu, Chunhui Liu, Fenxia Lin, Huijun Li iD, Hao Cheng, Jian He, Zuguo Zheng iD

ACS Sensors · 2026

DOI: 10.1021/acssensors.6c01742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Yanrong Wen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoplastic Cells, Circulating, Spectrum Analysis, Raman, Single-Cell Analysis. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Medical Science and technology development Foundation,Nanjing Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The profound phenotypic heterogeneity of circulating tumor cells (CTCs) presents a major analytical challenge, demanding technologies capable of high-plex, quantitative single-cell profiling. Here, we introduce PRISM (Phenotypic Resolution via Immuno-SERS Mapping), a biosensing platform engineered to meet this challenge. The platform integrates a high-efficiency dual-antibody (anti-EpCAM/anti-CSV) capture substrate with a suite of seven spectrally orthogonal SERS nanoprobes, enabling crosstalk-free, multiplexed quantification of epithelial, mesenchymal, and stem-like (E-M-S) markers. We demonstrate the platform's robust analytical performance, including high capture efficiency for heterogeneous cell lines and excellent linearity. Its superior phenotypic resolving power was validated by quantitatively distinguishing canonical cell line archetypes and tracking dynamic protein expression shifts during induced epithelial-mesenchymal transition. Applying PRISM to CTCs from pancreatic cancer patients, we introduce a novel data analysis framework, including a 'Metastasis Potential Score' (MPS), to translate high-dimensional spectral data into a clinically relevant metric for risk stratification. Furthermore, longitudinal analysis of patient samples demonstrates the platform's utility as a dynamic monitoring tool, capable of tracking therapy-induced phenotypic shifts. PRISM establishes a powerful analytical methodology for high-dimensional single-cell analysis, providing a robust tool for both fundamental cancer biology research and translational clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoplastic Cells, CirculatingSpectrum Analysis, RamanSingle-Cell AnalysisHumansPhenotypeEpithelial Cell Adhesion MoleculeCell Line, TumorEpithelial-Mesenchymal TransitionNeoplasm Metastasis

Stichwörter der Autor:innen

SERS biosensorcirculating tumor cellsliquid biopsymultiplexed detectionpancreatic cancerphenotypic heterogeneitysingle cell analysis

Substanzen

Epithelial Cell Adhesion Molecule

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing211198, China.
  • Physics and Chemistry Test Center of Jiangsu Province, Nanjing210042, China.
  • Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China.

ORCID-Profile: Yanrong Wen, Huijun Li, Zuguo Zheng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Medical Science and technology development Foundation,Nanjing Department of Health
  • Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University

Zitieren

APA

Wen, Y., Liu, M., Liu, C., Lin, F., Li, H., Cheng, H., He, J., & Zheng, Z. (2026). High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer. ACS Sensors. https://doi.org/10.1021/acssensors.6c01742

Vancouver

Wen Y, Liu M, Liu C, Lin F, Li H, Cheng H, et al. High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer. ACS Sensors. 2026. doi:10.1021/acssensors.6c01742

BibTeX
@article{Wen2026,
  author = {Wen, Yanrong and Liu, Mengxiang and Liu, Chunhui and Lin, Fenxia and Li, Huijun and Cheng, Hao and He, Jian and Zheng, Zuguo},
  title = {High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.6c01742}
}
Kostenlos starten →